SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-180410
Filing Date
2022-06-24
Accepted
2022-06-23 18:58:33
Documents
14
Period of Report
2022-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d267589d8k.htm   iXBRL 8-K 26524
2 EX-99.1 d267589dex991.htm EX-99.1 18703
6 GRAPHIC g267589g42y28.jpg GRAPHIC 8122
  Complete submission text file 0001193125-22-180410.txt   184244

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220621.xsd EX-101.SCH 2534
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220621_lab.xml EX-101.LAB 18035
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220621_pre.xml EX-101.PRE 11326
8 EXTRACTED XBRL INSTANCE DOCUMENT d267589d8k_htm.xml XML 3449
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 221036627
SIC: 2834 Pharmaceutical Preparations